The year in Google updates is well underway today with beta version 17.0 of the Google app on Android increasing the size of the app icon.

ProPublica is a nonprofit newsroom that investigates abuses of power. Sign up to receive our biggest stories as soon as they’re published. Join us Jan. 14 for a virtual discussion about our Rx ...

What is the best application server? The answer depends on what an enterprise is looking for. Compare Apache Tomcat to these four offerings to see which Java app server fits. Continue Reading ...

Patients in Canada may have to wait longer to access generic versions of Ozempic because of continuing delays in processing of new drug submissions at Health Canada, according to Swiss generic drug ...

Federal officials have approved another generic version of the abortion pill mifepristone, a regulatory formality that quickly triggered pushback from anti-abortion groups aligned with the Trump ...

The decision enraged opponents of abortion, who have been pressuring the Trump administration to restrict access to abortion medication. By Pam Belluck The Food and Drug Administration has approved a ...

After inking a related patent settlement last year, Viatris has cleared another obstacle in its quest to launch generic versions of Novo Nordisk’s lucrative semaglutide drugs for diabetes and obesity.

Generic brands, sometimes referred to as "private label" or "store brands," are increasingly popular today as shoppers face rising food prices in grocery stores. Some consumers believe these brands to ...

Tesla’s attempt to trademark the term “Robotaxi” in reference to its vehicles has been refused by the U.S. Patent and Trademark Office for being too generic, according to a new filing. Another ...

The Federal Circuit’s holding emphasizes the importance of including an inventive concept in future applications of machine learning if an inventor wishes to obtain or enforce a patent. As the Federal ...

President Donald Trump’s promise to impose tariffs on pharmaceutical imports is raising red flags among generic drugmakers and industry experts, who warn that such a move could lead to increased drug ...